Disclosed herein is a transdermal composition comprising: S-ibuprofen in an amount between about 1% and about 30% by weight of the composition; hydroxypropyl cellulose; a pharmaceutically acceptable non-volatile solvent; water; and isopropyl myristate; with the proviso that the apparent pH is not 7.0. Also disclosed is the use of the composition for the treatment of pain and inflammation.